382 related articles for article (PubMed ID: 37955798)
1. Methyl-CpG-Binding Protein 2 Emerges as a Central Player in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Mehmood A; Shah S; Guo RY; Haider A; Shi M; Ali H; Ali I; Ullah R; Li B
Cell Mol Neurobiol; 2023 Nov; 43(8):4071-4101. PubMed ID: 37955798
[TBL] [Abstract][Full Text] [Related]
2. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review.
Shahmohammadi S; Doosti R; Shahmohammadi A; Mohammadianinejad SE; Sahraian MA; Azimi AR; Harirchian MH; Asgari N; Naser Moghadasi A
Mult Scler Relat Disord; 2019 Jan; 27():350-363. PubMed ID: 30476871
[TBL] [Abstract][Full Text] [Related]
4. Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder.
Uzawa A; Mori M; Masuda H; Ohtani R; Uchida T; Aoki R; Kuwabara S
Clin Exp Immunol; 2020 Nov; 202(2):239-248. PubMed ID: 32643149
[TBL] [Abstract][Full Text] [Related]
5. Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.
Fragomeni MO; Bichuetti DB; Oliveira EML
Mult Scler Relat Disord; 2018 Oct; 25():138-142. PubMed ID: 30075406
[TBL] [Abstract][Full Text] [Related]
6. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.
Kong BS; Kim Y; Kim GY; Hyun JW; Kim SH; Jeong A; Kim HJ
J Neuroinflammation; 2017 Sep; 14(1):191. PubMed ID: 28946890
[TBL] [Abstract][Full Text] [Related]
7. Resolution of inflammation in neuromyelitis optica spectrum disorders.
Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).
KhorshidAhmad T; Acosta C; Cortes C; Lakowski TM; Gangadaran S; Namaka M
Mol Neurobiol; 2016 Mar; 53(2):1092-1107. PubMed ID: 25579386
[TBL] [Abstract][Full Text] [Related]
9. The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population.
Liang H; Gao W; Liu X; Liu J; Mao X; Yang M; Long X; Zhou Y; Zhang Q; Zhu J; Wang S; Jin T
J Neuroimmunol; 2019 Dec; 337():577045. PubMed ID: 31520790
[TBL] [Abstract][Full Text] [Related]
10. Different blood-brain-barrier disruption profiles in multiple sclerosis, neuromyelitis optica spectrum disorders, and neuropsychiatric systemic lupus erythematosus.
Jasiak-Zatońska M; Pietrzak A; Wyciszkiewicz A; Więsik-Szewczyk E; Pawlak-Buś K; Leszczyński P; Kozubski W; Michalak S; Kalinowska-Łyszczarz A
Neurol Neurochir Pol; 2022; 56(3):246-255. PubMed ID: 35118639
[TBL] [Abstract][Full Text] [Related]
11. Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disorders.
Brill L; Lavon I; Vaknin-Dembinsky A
Mult Scler Relat Disord; 2019 May; 30():114-118. PubMed ID: 30771576
[TBL] [Abstract][Full Text] [Related]
12. Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders.
Yick LW; Tang CH; Ma OK; Kwan JS; Chan KH
J Neuroinflammation; 2020 Aug; 17(1):236. PubMed ID: 32782018
[TBL] [Abstract][Full Text] [Related]
13. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
[TBL] [Abstract][Full Text] [Related]
14. Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease.
Li EC; Zheng Y; Cai MT; Lai QL; Fang GL; Du BQ; Shen CH; Zhang YX; Wu LJ; Ding MP
Epilepsia; 2022 Sep; 63(9):2173-2191. PubMed ID: 35652436
[TBL] [Abstract][Full Text] [Related]
15. Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin Damage.
Khorshid Ahmad T; Zhou T; AlTaweel K; Cortes C; Lillico R; Lakowski TM; Gozda K; Namaka MP
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604632
[TBL] [Abstract][Full Text] [Related]
16. Sex and gender differences in autoimmune demyelinating CNS disorders: Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD).
Diem L; Hammer H; Hoepner R; Pistor M; Remlinger J; Salmen A
Int Rev Neurobiol; 2022; 164():129-178. PubMed ID: 36038203
[TBL] [Abstract][Full Text] [Related]
17. Rapid Discrimination of Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis Using Machine Learning on Infrared Spectra of Sera.
El Khoury Y; Gebelin M; de Sèze J; Patte-Mensah C; Marcou G; Varnek A; Mensah-Nyagan AG; Hellwig P; Collongues N
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269934
[TBL] [Abstract][Full Text] [Related]
18. Elevated chemokines and cytokines for eosinophils in neuromyelitis optica spectrum disorders.
Du L; Chang H; Xu W; Zhang X; Yin L
Mult Scler Relat Disord; 2021 Jul; 52():102940. PubMed ID: 33930716
[TBL] [Abstract][Full Text] [Related]
19. Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Bauer A; Rudzki D; Berek K; Dinoto A; Lechner C; Wendel EM; Hegen H; Deisenhammer F; Berger T; Höftberger R; Rostasy K; Mariotto S; Reindl M
Front Immunol; 2022; 13():1037812. PubMed ID: 36451827
[TBL] [Abstract][Full Text] [Related]
20. The causal relationship between neuromyelitis optica spectrum disorder and other autoimmune diseases.
Wang X; Shi Z; Zhao Z; Chen H; Lang Y; Kong L; Lin X; Du Q; Wang J; Zhou H
Front Immunol; 2022; 13():959469. PubMed ID: 36248893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
